Infant Resuscitation

FOR THE TREATMENT OF BIRTH ASPHYXIA

Treatment
Treatment
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT
  • OVERVIEW
  • TECHNOLOGY Characteristics
  • Infant Resuscitation
    Representative Product

    Global annual deaths associated with birth asphyxia

    Condition
    Birth asphyxia is the failure to initiate and sustain breathing at birth. About one in twenty newborn babies fail to breath spontaneously and require resuscitation. Nearly one million of these infants die and others have damage from the lack of oxygen in the critical minutes after birth. 

    Mechanism of Action
    All resuscitation is based on the mechanical ventilation of the lungs with the aim of initiating spontaneous breathing. There are several types of equipment to help this process. Tube and mask devices use the operator’s breath to ventilate the infant. Self-inflating bag and mask devices use a self-inflating elastic bulb which is compressed to ventilate the infant. Flow-inflating bag and mask uses pressurized air, but requires the operator to compress a bag to ventilate the patient. T-piece mechanical devices have a pressurized gas source which the operator typically controls by manually covering and uncovering a valve. These methods help after the mouth has been suctioned out and may be combined with chest compression in some cases. 

    Current Use in High-Resource Settings
    Resuscitation using flow-inflating and T-piece devices are more common in high-resource settings, with the majority of American hospitals using T-piece devices bundled into resuscitation systems like the CosyCot. In the relatively rare cases when basic resuscitation fails, it is often supplemented with oxygen, tracheal intubation, and the use of intravenous epinephrine or plasma volume expanders. When initial resuscitation fails, CPAP or mechanical ventilation are used.

    Application in Low-Resource Settings
    Self-inflating bag and mask devices are the preferred technology in low-resource settings, and have been successfully deployed in homes and clinics. Ideal bag and mask devices are reusable, have a pressure relief valve (to prevent lung damage), have minimal dead airspace (to increase efficiency) and are designed for easy cleaning between uses. In 2006, PATH embarked on a global inventory of bag and mask devices, cataloging over 50 disposable devices from $3-$106 and over 50 reusable devices from $8-$310. 

     

    Related Technologies in Development

    PATH Neonatal Resuscitator

    REPRESENTATIVE DEVICES

    MAKE
    MODEL
    PRICE*
    TECH
    STATUS
    NOTES

    Laerdal

    Silcone
    $225
    Self-inflating
    Marketed
    High end, ergonomic device

    Besmed

    RS-2703
    $20
    Self-inflating
    Marketed
    Good value device

    Laerdal

    NeoNatalie
    $15
    Self-inflating
    Marketed
    Lower cost Laerdal product

    Zeal

    BlowSafe
    $9
    Tube
    Marketed
    Users report fatigue in operation

    * Prices are approximated. Actual pricing can, and will vary by marketplace and market conditions.

  • CHARACTERISTICS OF REPRESENTATIVE PRODUCT

    TECHNOLOGY CHARACTERISTICS

    OPERATIONAL PARAMETERS

    POTENTIAL OPPORTUNITIES FOR IMPROVEMENT

    SKILLS

    REQUIRED

    Intended end user
    Training required
    Time required per use
    Physician, nurse, SBA
    Hours-days
    <30 minutes

    Adequate training remains the greatest challenge in increasing the coverage and correct use of neonatal resuscitators.

    ENVIRONMENT/ INFRASTRUCTURE

    Power required
    Waste collection
    Complementary technologies required
    Temperature and storage
    Maintenance
    None
    Clock, two sizes of infant masks
    Must be sterilized between uses, likely with autoclave

    Skilled birth attendants can carry out some resuscitation even in the home.

    COST

    Device Cost (Approx)
    Cost/course (Approx)
    $10 - $20
    $0

    OTHER

    Portability
    Regulatory
    Efficacy
    <500g

    Additional devices required for impact: Suction bulb or DeLee and infant warmer. In more severe cases, oxygen, epinephrine, and more advanced respiratory care.

Sources: Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet 2005;365:891-900. PATH. Practical selection of neonatal resuscitators. Version 2. November 2006. PATH. Comparative study of the functionality and acceptability of four neonatal resuscitation devices. May 2008. PATH. Global inventory of neonatal resuscitators. June 2006. WHO. Basic newborn resuscitation: a practical guide. Safe Motherhood Project. 1997. The American Heart Association. 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Part 7: Neonatal Resuscitation January 2005. Dempsey E, Barrington KJ, Pammi M, Ryan A. Formal resuscitation training courses for reducing mortality and morbidity in newborn infants (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD009106. DOI: 10.1002/14651858.CD009106.Schmölzer GM, Morley CJ, Davis PG. Respiratory function monitoring to reduce mortality and morbidity in newborn infants receiving resuscitation. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD008437. DOI: 10.1002/14651858.CD008437.pub2. International Liaison Committee on Resuscitation. 2005 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Part 7: Neonatal resuscitation. Resuscitation 2005;67(2-3):293-303.